The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139

Goodman & Gilman's The Pharmacological Basis of Therapeutics

Brunton, L. L. (1985) · Cited by 7,321

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892

How to improve R&D productivity: the pharmaceutical industry's grand challenge

Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305

Targeting cancer with small molecule kinase inhibitors

Zhang, J., Yang, P. L., & Gray, N. S. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2559 · Cited by 2,648

Protein kinases — the major drug targets of the twenty-first century?

Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,232

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,832

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798

Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions

Heifetz, A., Aldeghi, M., Chudyk, E. I., Fedorov, D. G., Bodkin, M. J., & Biggin, P. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150250 · Cited by 35

A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015

O’Brien, Z., & Moghaddam, M. F. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170523124441 · Cited by 35

Kinetic operational models of agonism for G-protein-coupled receptors

Hoare, S. R. J., Pierre, N., Moya, A. G., & Larson, B. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.02.014 · Cited by 37

Protein target identification of ginsenosides in skeletal muscle tissues: discovery of natural small-molecule activators of muscle-type creatine kinase

Chen, F., Zhu, K., Chen, L., Ouyang, L., Chen, C., Gu, L., Jiang, Y., Wang, Z., Lin, Z., Zhang, Q., et al. (2019) · Journal of Ginseng Research · doi:10.1016/j.jgr.2019.02.005 · Cited by 35

GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease

Leysen, H., Walter, D., Christiaenssen, B., Vandoren, R., Harputluoğlu, İ., Loon, N. V., & Maudsley, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413387 · Cited by 34

Exploring Scoring Function Space: Developing Computational Models for Drug Discovery

Bitencourt‐Ferreira, G., Villarreal, M. A., Quiroga, R., Biziukova, N. Y., Poroikov, V., Tarasova, O. A., & de Azevedo, W. F. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230321103731 · Cited by 34

Host-directed therapies to combat tuberculosis and associated non-communicable diseases

Baindara, P. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.03.003 · Cited by 35

OMICs Technologies for Natural Compounds-based Drug Development

Aborode, A. T., Awuah, W. A., Mikhailova, T., Rahman, T. A., Pavlock, S., Kundu, M., Yarlagadda, R., Pustake, M. V., Correia, I. F. S., Mehmood, Q., et al. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220726092034 · Cited by 34

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

Bondarev, A. D., Jonsson, J., Chubarev, V. N., Tarasov, V. V., Lagunas‐Rangel, F. A., & Schiöth, H. B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107431 · Cited by 34

Structure and function of G protein‐coupled receptor oligomers: implications for drug discovery

Schonenbach, N. S., Hussain, S., & O’Malley, M. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1319 · Cited by 33

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets

Lago, S. G., & Bahn, S. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00290-4 · Cited by 31

Long way up: rethink diseases in light of phase separation and phase transition

Ding, M., Xu, W., Pei, G., & Li, P. (2023) · Protein & Cell · doi:10.1093/procel/pwad057 · Cited by 32

Computational structure modeling for diverse categories of macromolecular interactions

Aderinwale, T. W., Christoffer, C. W., Sarkar, D., Alnabati, E., & Kihara, D. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.05.017 · Cited by 31

Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders

Chen, Y., & Palczewski, K. (2015) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103033 · Cited by 31

Identification of natural products as novel ligands for the human 5-HT2C receptor

Peng, Y., Zhao, S., Wu, Y., Cao, H., Xu, Y., Liu, X., Shui, W., Cheng, J., Zhao, S., Shen, L., et al. (2018) · Biophysics Reports · doi:10.1007/s41048-018-0047-1 · Cited by 29

Review and comparative assessment of similarity-based methods for prediction of drug–protein interactions in the druggable human proteome

Wang, C., & Kurgan, L. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby069 · Cited by 32

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines

Chhibber, A., French, C. E., Yee, S. W., Gamazon, E. R., Theusch, E., Qin, X., Webb, A., Papp, A. C., Wang, A., Simmons, C. Q., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.93 · Cited by 29

COMSAT: Residue contact prediction of transmembrane proteins based on support vector machines and mixed integer linear programming

Zhang, H., Huang, Q., Bei, Z., Wei, Y., & Floudas, C. A. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24979 · Cited by 29

Guiding lead optimization with GPCR structure modeling and molecular dynamics

Heifetz, A., James, T., Morao, I., Bodkin, M. J., & Biggin, P. C. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.06.004 · Cited by 29

Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence

Deaton, A. M., Fan, F., Zhang, W., Nguyen, P. A., Ward, L. D., & Nioi, P. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy265 · Cited by 29

Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins

Ghadermarzi, S., Li, X., Li, M., & Kurgan, L. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01075 · Cited by 30

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

Bhat, R. R., Thangavel, H., Abdulkareem, N. M., Vasaikar, S. V., Angelis, C. D., Bae, L., Cataldo, M. L., Nanda, S., Fu, X., Zhang, B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05949-7 · Cited by 32

Application of Negative Design To Design a More Desirable Virtual Screening Library

Yang, Z., He, J.-H., Lü, A., Hou, T., & Cao, D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01476 · Cited by 29

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Kondo, T., Hara, N., Koyama, S., Yada, Y., Tsukita, K., Nagahashi, A., Ikeuchi, T., Ishii, K., Asada, T., Arai, T., et al. (2022) · Nature Aging · doi:10.1038/s43587-021-00158-9 · Cited by 26

Orphan G Protein-Coupled Receptor GPR37 as an Emerging Therapeutic Target

Bolinger, A. A., Frazier, A., La, J., Allen, J., & Zhou, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00479 · Cited by 28

Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions

Monfared, R. V., Alhassen, W., Truong, T. M., Gonzales, M. A. M., Vachirakorntong, V., Chen, S., Baldi, P., Civelli, O., & Alachkar, A. (2021) · Cells · doi:10.3390/cells10112967 · Cited by 28

Discoveries of GPR39 as an evolutionarily conserved receptor for bile acids and of its involvement in biliary acute pancreatitis

Zi, Z., & Rao, Y. (2024) · Science Advances · doi:10.1126/sciadv.adj0146 · Cited by 27

Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders

Cao, D., Zhang, P., & Wang, S. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.004 · Cited by 30

GPCRtm: An amino acid substitution matrix for the transmembrane region of class A G Protein-Coupled Receptors

Ríos, S., Fernandez, M. F., Caltabiano, G., Campillo, M., Pardo, L., & González, Á. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0639-4 · Cited by 26

Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery

Heifetz, A., Southey, M. W. Y., Morao, I., Townsend‐Nicholson, A., & Bodkin, M. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7465-8_19 · Cited by 26

Emerging protein kinase inhibitors for the treatment of multiple myeloma

Lind, J., Czernilofsky, F., Vallet, S., & Podar, K. (2019) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2019.1647165 · Cited by 25

High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins

Holbrook‐Smith, D., Durot, S., & Sauer, U. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110767 · Cited by 25

The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor

Bueschbell, B., Manga, P., & Schiedel, A. C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.873777 · Cited by 24

Evidence-Based Precision Oncology with the Cancer Targetome

Blucher, A., Choonoo, G., Kulesz-Martin, M. F., Wu, G., & McWeeney, S. K. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.006 · Cited by 24

Technological advances for interrogating the human kinome

Baharani, A., Trost, B., KUSALIK, A. J., & Napper, S. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160163 · Cited by 22

Kinase inhibitors as potential agents in the treatment of multiple myeloma

Abramson, H. N. (2016) · Oncotarget · doi:10.18632/oncotarget.10745 · Cited by 23

Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection

Saikia, S., Bordoloi, M., & Sarmah, R. (2018) · Current Drug Targets · doi:10.2174/1389450120666181105152439 · Cited by 23

Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration

Park, C., Lee, J. W., Kim, K., Seen, D., Jeong, J.-Y., & Huh, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-28531-1 · Cited by 24

Druggability of Coronary Artery Disease Risk Loci

Tragante, V., Hemerich, D., Alshabeeb, M. A., Brænne, I., Lempiäinen, H., Patel, R. S., den Ruijter, H. M., Barnes, M. R., Moore, J. H., Schunkert, H., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001977 · Cited by 22

Genomic variant annotation workflow for clinical applications

Thurnherr, T., Singer, F., Stekhoven, D. J., & Beerenwinkel, N. (2016) · F1000Research · doi:10.12688/f1000research.9357.1 · Cited by 20

Opportunities and challenges for the development of covalent chemical immunomodulators

Backus, K. M., Cao, J. X., & Maddox, S. M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.050 · Cited by 21

Targeting G protein-coupled receptors in cancer therapy

Soond, S. M., & Zamyatnin, A. A. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.11.002 · Cited by 23

Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk

Tragante, V., Asselbergs, F. W., Swerdlow, D. I., Palmer, T., Moore, J. H., de Bakker, P. I. W., Keating, B. J., & Holmes, M. V. (2016) · Human Genetics · doi:10.1007/s00439-016-1647-9 · Cited by 21

Innovative Computer-Aided Methods for the Discovery of New Kinase Ligands

Abuhammad, A., & Taha, M. O. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2015-0003 · Cited by 21

Genomics of drug target prioritization for complex diseases

Chen, R. K., Duffy, Á., & Do, R. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00904-4 · Cited by 28

Functional genomic analysis of Candida albicans protein kinases reveals modulators of morphogenesis in diverse environments

Lee, Y., Hossain, S., MacAlpine, J., Robbins, N., & Cowen, L. E. (2023) · iScience · doi:10.1016/j.isci.2023.106145 · Cited by 19

Auto-induction of Pichia pastoris AOX1 promoter for membrane protein expression

Lee, J. Y., Chen, H., Liu, A., Alba, B. M., & Lim, A. C. (2017) · Protein Expression and Purification · doi:10.1016/j.pep.2017.06.006 · Cited by 20

Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer

Lian, J., Lin, S., Ye, Y., Chang, D. W., Huang, M., Dinney, C. P., & Wu, X. (2018) · Oncotarget · doi:10.18632/oncotarget.24473 · Cited by 21

Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors

Kalinichenko, Е. N., Faryna, A., Kondrateva, V., Vlasova, A., Shevchenko, V., Mel’nik, A. K., Avdoshko, O., & Belko, A. (2019) · Molecules · doi:10.3390/molecules24193543 · Cited by 20

Comparative phosphoproteomic analysis unravels MAPK1 regulated phosphoproteins in Leishmania donovani

Kaur, P., Anand, A., Bhat, A., Maras, J. S., & Goyal, N. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104189 · Cited by 20

Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method

Chudyk, E. I., Sarrat, L., Aldeghi, M., Fedorov, D. G., Bodkin, M. J., James, T., Southey, M. W. Y., Robinson, R., Morao, I., & Heifetz, A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7465-8_8 · Cited by 19

Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications

Mariño‐Enríquez, A. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.06.001 · Cited by 19

Nanodiscs and mass spectrometry: Making membranes fly

Marty, M. T. (2020) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2020.116436 · Cited by 21

Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies

Ju, M., & Jung, S. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218240 · Cited by 18

Strategies towards Targeting Gαi/s Proteins: Scanning of Protein‐Protein Interaction Sites To Overcome Inaccessibility

Nubbemeyer, B., Pepanian, A., George, A. A. P., & Imhof, D. (2021) · ChemMedChem · doi:10.1002/cmdc.202100039 · Cited by 18

Ligand Similarity Complements Sequence, Physical Interaction, and Co-Expression for Gene Function Prediction

O’Meara, M. J., Ballouz, S., Shoichet, B. K., & Gillis, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160098 · Cited by 15

Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data

Ryall, K. A., Shin, J., Yoo, M., Hinz, T. K., Kim, J., Kang, J., Heasley, L. E., & Tan, A. C. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv427 · Cited by 17

GPR114/ADGRG5 is activated by its tethered peptide agonist because it is a cleaved adhesion GPCR

Bernadyn, T. F., Vizurraga, A., Adhikari, R., Kwarcinski, F. E., & Tall, G. G. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105223 · Cited by 17

Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality

Li, Z., Jiang, J., Ficarro, S. B., Beyett, T. S., To, C., Tavares, I., Zhu, Y., Li, J., Eck, M. J., Janne, P. A., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01245 · Cited by 17

G Protein–Coupled Receptor Heteromers in Brain: Functional and Therapeutic Importance in Neuropsychiatric Disorders

Sun, Y., Hasbi, A., & George, S. R. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080727 · Cited by 18

At The Interface: Small-Molecule Inhibitors of Soluble Cytokines

Raavi, Koehler, A. N., & Vegas, A. J. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00469 · Cited by 18

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Zhang, C., Cui, M., Cui, Y., Hettinghouse, A., & Liu, C.-J. (2019) · Journal of Visualized Experiments · doi:10.3791/59656 · Cited by 17

Beyond the Nucleus: Plastic Chemicals Activate G Protein-Coupled Receptors

McPartland, M., Stevens, S., Bartošová, Z., Vardeberg, I. G., Völker, J., & Wagner, M. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.3c08392 · Cited by 16

Design, Synthesis and Preliminary Biological Evaluation of Novel Benzyl Sulfoxide 2-Indolinone Derivatives as Anticancer Agents

Tang, L., Peng, T., Wang, G., Wen, X., Sun, Y., Zhang, S., Liu, S., & Wang, L. (2017) · Molecules · doi:10.3390/molecules22111979 · Cited by 14

The Role of Liquid-Liquid Phase Separation in the Accumulation of Pathological Proteins: New Perspectives on the Mechanism of Neurodegenerative Diseases

Lu, X., Lu, J., Li, S., Feng, S., Wang, Y., & Cui, L. (2024) · Aging and Disease · doi:10.14336/ad.2024.0209 · Cited by 17

Applications of Functional Genomics for Drug Discovery

Kabadi, A. M., McDonnell, E., Frank, C. L., & Drowley, L. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220902092 · Cited by 15

PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures

Emon, M. A., Domingo‐Fernándéz, D., Hoyt, C. T., & Hofmann‐Apitius, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03568-5 · Cited by 12

Increased Anxiety-like Behaviors in Adgra1−/− Male But Not Female Mice are Attributable to Elevated Neuron Dendrite Density, Upregulated PSD95 Expression, and Abnormal Activation of the PI3K/AKT/GSK-3β and MEK/ERK Pathways

Zhang, X.-H., Shen, C., Wang, X., Xiong, W., Shang, X., Tang, L., Zhang, H., Wan, Y.-H., Wu, Y., Fei, J., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.003 · Cited by 13

Construction and Applications of Mammalian Cell-Based DNA-Encoded Peptide/Protein Libraries

Wang, Y., Zhang, K., Zhao, Y., Li, Y., Su, W., & Li, S. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00043 · Cited by 13

Detergents: Friends not foes for high‐performance membrane proteomics toward precision medicine

Zhang, X. (2016) · PROTEOMICS · doi:10.1002/pmic.201600209 · Cited by 14

G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example

Wang, X., van Westen, G. J. P., Heitman, L. H., & IJzerman, A. P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114370 · Cited by 12

Transient Transfection and Expression of Eukaryotic Membrane Proteins in Expi293F Cells and Their Screening on a Small Scale: Application for Structural Studies

Krasnoselska, G. O., Dumoux, M., Gamage, N., Cheruvara, H., Birch, J., Quigley, A., & Owens, R. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1406-8_5 · Cited by 12

The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush

Teng, M., Young, D. W., & Tan, Z. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01291 · Cited by 12

Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands

Freudenberg, J., Dunham, I., Sanséau, P., & Rajpal, D. K. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2392-y · Cited by 12

Management of Obesity in Adults

SKOLNIK, N., & Ryan, D. H. (2014) · Cited by 12

In vitro affinity maturation of antibody against membrane-bound GPCR molecules

Wang, J., An, L., Zhao, Y., Zhang, C., Li, S., Ye, C., Jing, S., & Hang, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10030-x · Cited by 11

Small-molecule probe for IBD risk variant GPR65 I231L alters cytokine signaling networks through positive allosteric modulation

Neale, I., Reddy, C. S., Tan, Z. Y., Li, B., Nag, P. P., Park, J., Park, J. J. H. S. J. A. Y., Carey, K. L., Graham, D. B., & Xavier, R. J. (2024) · Science Advances · doi:10.1126/sciadv.adn2339 · Cited by 11

The Chemerin Receptor CMKLR1 Requires Full‐Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase‐Based Binding Assay

Czerniak, A. S., Kretschmer, K., Weiß, T., & Beck‐Sickinger, A. G. (2022) · ChemMedChem · doi:10.1002/cmdc.202200413 · Cited by 10

Topology based identification and comprehensive classification of four-transmembrane helix containing proteins (4TMs) in the human genome

Attwood, M. M., Krishnan, A., Pivotti, V., Yazdi, S., Almén, M. S., & Schiöth, H. B. (2016) · BMC Genomics · doi:10.1186/s12864-016-2592-7 · Cited by 11

Harnessing public domain data to discover and validate therapeutic targets

Reisdorf, W. C., Chhugani, N., Sanséau, P., & Agarwal, P. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1329296 · Cited by 11

Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia

Hatzipantelis, C. J., Langiu, M., Vandekolk, T. H., Pierce, T. L., Nithianantharajah, J., Stewart, G. D., & Langmead, C. J. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00117 · Cited by 13

Basidiomycete‐specific PsCaMKL1 encoding a CaMK‐like protein kinase is required for full virulence of Puccinia striiformis f. sp. tritici

Jiao, M., Yu, D., Tan, C., Guo, J., Lan, D., Han, E., Qi, T., Voegele, R. T., Kang, Z., & Guo, J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13881 · Cited by 11

Evidence of G-Protein-Coupled Receptors (GPCR) in the Parasitic Protozoa Plasmodium falciparum—Sensing the Host Environment and Coupling within Its Molecular Signaling Toolkit

Pereira, P. H. S., & Garcia, C. R. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212381 · Cited by 10

Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor

Heydenreich, F. M., Plouffe, B., Rizk, A., Milić, D., Zhou, J., Breton, B., Gouill, C. L., Inoue, A., Bouvier, M., & Veprintsev, D. B. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000497 · Cited by 10

NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling

Shin, Y., Jung, W., Kim, M., Shin, D., Kim, G.-H., Kim, C. H., Park, S.-H., Cho, E., Choi, D. W., Han, C. J., et al. (2022) · Cancers · doi:10.3390/cancers14235850 · Cited by 10

Enhanced Fluorescence Resonance Energy Transfer in G-Protein-Coupled Receptor Probes on Nanocoated Microscopy Coverslips

Schreiber, B., Kauk, M., Heil, H. S., Emmerling, M., Teßmer, I., Kamp, M., Höfling, S., Holzgrabe, U., Hoffmann, C., & Heinze, K. G. (2018) · ACS Photonics · doi:10.1021/acsphotonics.8b00072 · Cited by 11

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer

Lara, O. D., Bayraktar, E., Amero, P., Ma, S., Ivan, C., Hu, W., Wang, Y., Mangala, L. S., Dutta, P., Bhattacharya, P. K., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27667 · Cited by 10

Targeting β-Arrestins in the Treatment of Psychiatric and Neurological Disorders

Harris, S., & Urs, N. M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00796-y · Cited by 10

NMR spectroscopy of lipidic cubic phases

Rajput, S., Yao, S., Keizer, D. W., Sani, M., & Separovic, F. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00900-y · Cited by 10

Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy

Zhang, Y., Yuan, Z., Jin, Y., Zhang, W., & Yuan, W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122058 · Cited by 10

Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure

Dhalla, N. S., Bhullar, S. K., Adameová, A., Mota, K. O., & de Vasconcelos, C. M. L. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2409264 · Cited by 9

Monocarbonyl synthetic curcumin analogues with antitumour potential. Chemical and biological aspects

Неганова, М. Е., Александрович, Ю. П., Aleksandrova, Y. R., & Brel, V. K. (2025) · Russian Chemical Reviews · doi:10.59761/rcr5189 · Cited by 10

Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process

Maudsley, S. R., Walter, D., Schrauwen, C., Loon, N. V., Harputluoğlu, İ., Lenaerts, J., & McDonald, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113598 · Cited by 9

A simple linearization method unveils hidden enzymatic assay interferences

Pinto, M. F., Ripoll‐Rozada, J., Ramos, H., Watson, E. E., Franck, C., Payne, R. J., Saraiva, L., Pereira, P. J. B., Pastore, A., Rocha, F. A., et al. (2019) · Biophysical Chemistry · doi:10.1016/j.bpc.2019.106193 · Cited by 9

Structural basis for the binding of a selective inverse agonist AF64394 with the human G-protein coupled receptor 3 (GPR3)

..., B., & Roy, K. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1940282 · Cited by 9

Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics

Lorenz, R., Wu, J., Herberg, F. W., Taylor, S. S., & Engh, R. A. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00359 · Cited by 9

Rethinking c-Fos for understanding drug action in the brain

Sakurai, K. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad110 · Cited by 8

Co-dependent regulation of p-BRAF and potassium channel KCNMA1 levels drives glioma progression

Xie, S., Xu, C., Wu, C., Lou, Y., Duan, J., Sang, R., Lou, Z., Hou, J., Ge, W., Xi, Y., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04708-9 · Cited by 8

Dynamics of ligand binding to GPCR: Residence time of melanocortins and its modulation

Rinken, A., Veikšina, S., & Kopanchuk, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.030 · Cited by 9

A Diversity‐Oriented Approach to Large Libraries of Artificial Macrocycles

Kharchenko, S., Iampolska, A. D., Radchenko, D. S., Vashchenko, B. V., Voïtenko, Z., & Grygorenko, O. O. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100195 · Cited by 8

Trends in the exploitation of novel drug targets

Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853

Trends in Exploration of Therapeutic Targets

Zheng, C. J., Han, L., Yap, C. W., Xie, B., & Chen, Y. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.2.886480 · Cited by 14

The Therapeutic Target Database: an Internet resource for the primary targets of approved, clinical trial and experimental drugs

Liu, X., Zhu, F., Ma, X., Tao, L., Zhang, J., Yang, S., Wei, Y., & Chen, Y. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.586635 · Cited by 24

The evolving landscape of drug targets

Halip, L., Avram, S. I., Overington, J. P., Al‐Lazikani, B., Curpan, R. F., Sirimulla, S., Pushechnikov, A. O., Beccari, A. R., Savchuk, N., & Oprea, T. I. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01530-3

Construction of Enriched Resource for Primary Therapeutic Targets of Approved and Clinical Trial Drugs

Yang, H. J., Yu, C., Li, Y., & Zhu, F. (2017) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2017.53001